Printer Friendly

Global Pyrogen Testing Market Growth at 12% CAGR Forecast to 2019.

DALLAS, February 24, 2015 /PRNewswire/ --

The global pyrogen testing market valued at $462.38 million in 2014 is poised to grow at a CAGR of 12.23% between 2014 and 2019, to reach $823.14 million in 2019, says a new pyrogen testing research available at ReportsnReports.com

Pyrogen testing is used to determine the presence of bacterial toxins in pharmaceutical, biotechnology, and medical device products, intended for medical or veterinary use. Spot checks of all batches of pharmaceutical, biotechnology, and medical device products are mandatory for regulatory approval and market release. Pyrogen testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the pyrogen testing market. Complete report on Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019 available at other-applications-global-forecast-to-2019.html

The global pharmaceutical industry is expected to grow at a CAGR between 5% and 8%. According to the IMS Institute of Healthcare Informatics, the global biologics market has increased from $46 billion in 2002 to $169 billion in 2012. Biologics accounted for a share of 11% of the total sales of drugs in 2002, which increased to 18% in 2012. It is estimated that this figure will rise to 20% by 2017, with a total market value of $221 billion.

The major players in the Pyrogen testing market are Associates of Cape Cod Inc, Charles River Laboratories International Inc, Lonza Group, Merck & Co. Inc, Wako Chemicals USA Inc, Ellab A/S, Genscript, Hyglos Gmbh, Sigma-Aldrich Corporation and Thermo Fisher Scientific Inc. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=344486

This report segments the pyrogen testing market on the basis of applications, products, tests, and geographies. The application segments included in this report are pharmaceuticals and biologicals, medical devices, and other applications. The product segments of this market are instruments, kits & reagents, and services. The test segments included in this report are in vitro test, LAL test, and rabbit pyrogen test. The report includes geographic analysis of the pyrogen testing market in 19 geographic and regional segments. The geographic segments included in this report are Asia, Europe, North America and the Rest of the World (RoW). The regional segments of Asia are China, India, Japan, and the Rest of Asia. The regional segments of Europe are France, Germany, Italy, Spain, the U.K., and the Rest of Europe. The regionals segments of North America are Canada and the U.S. The regional segments of RoW are Africa, Pacific and Oceania, and South America, Central America, &the Caribbean.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important sub segments. It maps market sizes and growth rates of each sub-segment and identifies segments poised for rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the pyrogen testing market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches. Priced at $4650 for a single user PDF, a discount on this research report can be requested at http://www.reportsnreports.com/contacts/Discount.aspx?name=344486

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global pyrogen testing market and its sub segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their pyrogen testing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth rates.

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

* Product Development/Innovation: Product portfolios of top players in the pyrogen testing market.

* Competitive Assessment: Analysis of market shares, strategies, geographic and business segments, and product portfolios of leading players in the pyrogen testing market

* Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various pyrogen testing products across geographies

* Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the pyrogen testing market

Other reports that may be of interest

"Microbiology Testing/Clinical Microbiology Market by Product (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics), Clinical Application (Periodontal Disease, Respiratory Diseases, STD, UTI) & by Industry - Global Forecast to 2019" research report is now available with ReportsnReports.com. Companies like Becton, Dickinson and Company, Biomerieux SA, Cepheid, Danaher Corporation, Siemens AG, Abbott Laboratories Inc, Alere Inc, Bio-Rad Laboratories Inc, Bruker Corporation, F. Hoffmann-LA Roche Ltd and Hologic Inc are discussed in this research available at odontal-disease-respiratory-diseases-std-uti-by-industry-global-forecast-to-2019.html

"Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019" research report is now available with ReportsnReports.com. Companies like Glaxosmithkline PLC, Merck & Co. Inc, SANOFI, Pfizer Inc, Bavarian Nordic, CSL Limited, Emergent Biosolutions Inc, Johnson & Johnson and Medimmune LLC. (A Subsidiary of Astrazeneca) are discussed in this research available at http://www.reportsnreports.com/reports/267258-vaccine-market-by-technology-types-and-by-indications-infectious-diseases-cancer-allergy-diabetes-cardiovascular-disease-with-market-landscape-analysis-global-forecasts-to-2022.html

Explore more Biotechnology Market Research Reports at http://www.reportsnreports.com/market-research/biotechnology/

About Us: ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.

Connect with Us:

G+ / Google Plus: https://plus.google.com/u/0/111656568937629536321/posts

Twitter: http://twitter.com/marketsreports

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

RSS / Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Contact: Siju K. TX, Dallas North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas 75252 Tel: +1-888-391-5441 sales@reportsandreports.com
COPYRIGHT 2015 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire Europe
Date:Feb 24, 2015
Words:1324
Previous Article:Global Plastic Bag Industry Report 2014 - Forecasts to 2020.
Next Article:Global Bluetooth Car Kit Industry Report 2015 - Analysis 2010-2015 & Forecasts 2015-2020.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters